We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
-18.82%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$1.03B
AUM Growth
-$200M
Cap. Flow
+$16M
Cap. Flow %
1.55%
Top 10 Hldgs %
58.26%
Holding
811
New
317
Increased
98
Reduced
90
Closed
269

Top Buys

Rank Stock Value
1
VAL icon
Valaris
VAL
+$24.3M
2
MRNA icon
Moderna
MRNA
+$9.63M
3
SLV icon
iShares Silver Trust
SLV
+$9.23M
4
TMUS icon
T-Mobile US
TMUS
+$9.02M
5
NE icon
Noble Corp
NE
+$6.74M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$107M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$29M
3
APTV icon
Aptiv
APTV
+$22.6M
4
MSFT icon
Microsoft
MSFT
+$20.8M
5
AMZN icon
Amazon
AMZN
+$12.7M

Sector Composition

Rank Sector Weight
1 Healthcare 23.31%
2 Consumer Discretionary 12.31%
3 Materials 12.15%
4 Industrials 5.19%
5 Financials 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LU icon
401
Lufax Holding
LU
$1.47B
$281K 0.03%
+11,722
New +$272K
MSBI icon
402
Midland States Bancorp
MSBI
$690M
$279K 0.03%
11,623
-7,832
-40% -$204K
VRT icon
403
Vertiv
VRT
$105B
$277K 0.03%
+33,677
New +$381K
ARW icon
404
Arrow Electronics
ARW
$10.5B
$276K 0.03%
2,461
-221
-8% -$25.8K
AAPL icon
405
PUT
Apple
AAPL
$4.47T
$273K 0.03%
2,000
-3,000
-60% -$454K
MCRB icon
406
Seres Therapeutics
MCRB
$48.6M
$272K 0.03%
+3,962
New +$341K
AAP icon
407
Advance Auto Parts
AAP
$3.36B
$271K 0.03%
+1,567
New +$311K
FINV
408
FinVolution Group
FINV
$1.1B
$269K 0.03%
56,527
-6,631
-10% -$26.7K
MASI
409
DELISTED
Masimo
MASI
$268K 0.03%
+2,054
New +$275K
UNIT
410
Uniti Group
UNIT
$2.3B
$268K 0.03%
+28,493
New +$329K
ORCL icon
411
Oracle
ORCL
$433B
$265K 0.03%
+3,787
New +$277K
TUP
412
DELISTED
Tupperware Brands Corporation
TUP
$263K 0.03%
+41,466
New +$463K
CRNT icon
413
Ceragon Networks
CRNT
$195M
$260K 0.03%
+101,096
New +$193K
SPG icon
414
Simon Property Group
SPG
$71.3B
$260K 0.03%
+2,741
New +$314K
DVA icon
415
DaVita
DVA
$11.7B
$259K 0.03%
+3,244
New +$328K
STX icon
416
Seagate
STX
$184B
$257K 0.03%
+3,597
New +$292K
QDEL icon
417
QuidelOrtho
QDEL
$882M
$256K 0.02%
+2,637
New +$269K
CLDT
418
Chatham Lodging
CLDT
$576M
$254K 0.02%
+24,268
New +$305K
GNW icon
419
Genworth Financial
GNW
$3.71B
$254K 0.02%
+71,913
New +$275K
AUTL
420
Autolus Therapeutics
AUTL
$572M
$253K 0.02%
89,356
CNMD icon
421
CONMED
CNMD
$1.49B
$253K 0.02%
+2,637
New +$316K
JYNT icon
422
The Joint Corp
JYNT
$122M
$253K 0.02%
16,503
+10,654
+182% +$238K
CAT icon
423
Caterpillar
CAT
$386B
$252K 0.02%
+1,410
New +$297K
ROCK icon
424
Gibraltar Industries
ROCK
$1.45B
$252K 0.02%
6,494
-26,209
-80% -$1.07M
ES icon
425
Eversource Energy
ES
$26.9B
$251K 0.02%
+2,968
New +$264K

Similar funds

Caxton Associates (New York)'s Q2 2022 Portfolio in Review

As of Q2 2022, Caxton Associates (New York) held 811 positions worth $1.03B, down 16% from $1.23B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Caxton Associates (New York)'s Q2 2022 filing shows 317 new, 98 increased, 90 reduced and 269 closed positions. Its largest new stake was Valaris: 451,426 shares worth $19.1M. The largest sale was Tesla, an estimated $107M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Materials.

  • Caxton Associates (New York)'s largest Q2 2022 buy was Valaris: 451,426 shares worth $19.1M.
  • Caxton Associates (New York) added most to Moderna in Q2 2022, an estimated $9.63M increase.
  • Caxton Associates (New York)'s biggest Q2 2022 reduction was Aptiv, cutting an estimated $22.6M.
  • Caxton Associates (New York) fully exited Tesla in Q2 2022, selling an estimated $107M.
  • Caxton Associates (New York)'s ten largest holdings make up 58% of its $1.03B portfolio in Q2 2022.
  • Caxton Associates (New York) opened 317 new positions and closed 269 in Q2 2022.
  • Caxton Associates (New York)'s portfolio value fell 16% quarter-over-quarter to $1.03B.

Based on Caxton Associates (New York)'s 13F filing for Q2 2022, filed 15 Aug 2022.